Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

Clinical trial NCT06037733 · RECRUITING

Trial details

NCT number: NCT06037733
Sponsor: Hubei Cancer Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Non-Small Cell Squamous Lung Cancer Radiotherapy Immunotherapy

Start date: 2024-03-13
Primary completion: 2026-03-13
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.